Interventional Cardiology Devices Market PPT: Demand, Trends and Business Opportunities 2023-28

1
Global Interventional Cardiology Devices Market
Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Interventional Cardiology Devices Market
Research Report The latest report by IMARC,
titled Interventional Cardiology Devices Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028 " the global
interventional cardiology devices market size
reached US 21.3 Billion in 2022.
Interventional cardiology devices refer to
medical tools and equipment used to diagnose and
treat cardiovascular diseases (CVDs). Some of the
common devices include stents, mitral, catheters,
angioplasty balloons, pulmonary and tricuspid
valves, plaque modification, and hemodynamic flow
alteration devices. These instruments are
widely used for medical procedures, such as
trans-myocardial laser revascularization (TMR),
angioplasty, coronary artery bypass grafting
(CABG), stenting, aneurysm repair, open-heart,
off-pump heart, and minimally invasive (MI) heart
surgeries. Interventional cardiology devices are
less painful and cost-effective, require a
shorter recovery period, suitable for infants and
children, and reduce the risk of heart
attacks. Request Free Sample Report
https//www.imarcgroup.com/interventional-cardiolo
gy-devices-market/requestsample
4
Report Description and Highlights
Report Description

Global Interventional Cardiology Devices Market
Trends The rising geriatric population prone to
chronic heart ailments across the globe is one of
the key factors driving the market growth.
Interventional cardiology devices are widely used
to treat vascular and cardiovascular illnesses
and capture embolic debris to ensure continuous
blood flow and prevent blockages. In line with
this, the increasing prevalence of CVDs on
account of sedentary lifestyles and unhealthy
dietary habits and patterns, such as smoking and
alcohol consumption, is favoring the market
growth. Additionally, the surging demand for
compact cardiovascular devices, such as a balloon
or stent, to open the obstructed artery, restore
blood supply, and cause minimal scarring, is
acting as another growth-inducing factor. Apart
from this, the introduction of bioabsorbable and
drug-eluting stents that help eliminate the
chances of blood clots forming in a stent is
providing an impetus to the market growth.
Moreover, the widespread utilization of advanced
imaging techniques, such as fractional flow
reserve (FFR) and intravenous ultrasound (IVUS),
for the early detection and prompt treatment of
CVDs is positively influencing the market growth.
Other factors, including rising expenditure
capacities, significant growth in the healthcare
industry, and shifting preferences toward MI
procedures, are anticipated to drive the market
growth. On account of the aforementioned factors,
the market value is expected to reach US 33.8
Billion by 2028, exhibiting a CAGR of 7.5 during
2023-2028. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Product Ste
nts Drug Eluting Stents
Bare Metal Stents Bio-
Absorbable Stents Interventional Cathete
rs IVUS Catheters
Guiding Catheters Angiograph
y Catheters PTCA Guidewires Ba
lloon Inflation Device PTCA Balloons
Cutting Balloons
Scoring Balloons
Drug Eluting Balloons
Normal Balloons
Breakup by End User

6
Report Description and Highlights
Report Description
Hospitals Ambulatory Surgical
Centers Others Breakup by Region
North America United States
Canada Asia-Pacific
China Japan
India South Korea
Australia
Indonesia Others Europ
e Germany Fran
ce United Kingdom

7
Report Description and Highlights
Report Description
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Abbott Laboratories Alvimedica B. Braun Melsungen
  AG Biosensors International Group Ltd. (Bluesail M
  edical Co. Ltd.) BIOTRONIK Inc. Boston Scientific
  Corporation Cook Group Incorporated ENDOCOR GmbH K
  oninklijke Philips N.V. Medinol Ltd. Medtronic plc
  Terumo Corporation.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/interventional-cardiolo
  gy-devices-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us